This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting central nervous system disorders, particularly as a building block for compounds with potential antidepressant or anxiolytic properties. Its chiral structure is significant in creating enantiomerically pure drugs, enhancing efficacy and reducing side effects. Additionally, it is explored in research for its potential use in designing novel therapeutics for chronic pain management and neurodegenerative diseases. Its trifluoromethyl group contributes to improved metabolic stability and bioavailability in drug formulations.